Publications Demonstrate Multiplexing, Clinical Potential of RainDance Digital PCR Tech
May 26, 2011
Publications Demonstrate Multiplexing, Clinical Potential of RainDance Digital PCR Tech
A pair of recently published research papers has demonstrated the high degree of sensitivity, clinical diagnostic potential, and multiplexing capability of digital PCR products under development at RainDance Technologies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Trovagene Bets on Digital PCR as Detection Technology for Urine-Based MDx Testing Platform
May 3, 2012 / PCR Insider - RainDance Launches Digital PCR Platform; Claims Sensitivity, Operating Cost Superiority
March 29, 2012 / PCR Insider - UC Irvine Team Details 1M-Droplet Array for Digital PCR, Claims Advantages over Other Methods
October 20, 2011 / PCR Insider - Life Tech Launches 'All-in-One' Digital and Real-Time PCR Platform
October 13, 2011 / PCR Insider - Bio-Rad Jumps into Digital PCR Space with $162M QuantaLife Buy
October 6, 2011 / PCR Insider